https://www.selleckchem.com/products/blu-554.html
Patients with primary tumor resection had significantly better 5-year survival rate (27.2 vs. 5.6%, P less then 0.001) compared to the non-resection group. Chemoradiotherapy with primary site resection was associated with the longest mean and 5-year OS (44.7 months, 32.4%). The Cox regression analyses of the subgroup indicated that patients who underwent primary tumor resection had improved survival compared with those who did not undergo resection in all 25 subgroups. Factors associated with primary tumor resection were well or moderat
Like
Comment
Share
